QSP Modeling for Dual Targeting Approaches for Two Immuno-oncology Therapeutics

Webinar Details

This webinar aired live Wednesday, April 12, 2016 at 2:00PM EST and was presented by Dr. John M. Burke, Co-Founder, President and CEO of Applied BioMath.

Biotech and Pharma are increasingly using quantitative systems pharmacology modeling (QSPM) approaches to help answer complex, critical Go/No-go decisions in R&D. In this webinar Dr. John Burke will discuss the value of QSP approaches by reviewing a QSP industry case study. 

The case study entails developing and interrogating a QSPM of PD-1 and TIM-3. The QSPM provided:

  • Biological insights by predicting why dosing regimens are quite similar for two therapeutics targeting PD-1 that have affinities that differ by several orders of magnitude
  • Best-in-class profile predictions for PD-1 and TIM-3 dual antagonists

This webinar is ideal for scientists in R&D who want to learn more about how to leverage QSPM to shorten timelines, lower cost, and increase the likelihood of developing best-in-class drugs.

View the Webinar